In vitro effects of ivermectin upon trichomonas vaginalis trophozoites

Francisco González-Salazar, Benito D. Mata-Cárdenas, Gerardo Rivera Silva, Jesús N. Garza-González, Elva I. Cortes-Gutiérrez, Javier Vargas-Villarreal

Research output: Contribution to journalArticlepeer-review

Abstract

Trichomoniasis is the most common, curable sexually transmitted disease in the world. The first line treatment of trichomoniasis is metronidazole. Recently, the resistance of T. vaginalis to metronidazole and imidazoles has been shown to increase. Ivermectin is a synthetic machrolid drug with activity versus endo and ectoparasitic organisms. In this assay, was tested the effects of ivermectin on T. vaginalis trophozoites. Ivermectin have anti-parasitic activity upon trichomonas trophozoites. However, the IC 50 of ivermectin against T. vaginalis was high compared with metronidazole.
Original languageEnglish
Pages (from-to)156-158
Number of pages3
JournalLatin American Journal of Pharmacy
Volume31
Issue number1
Publication statusPublished - 30 Apr 2012

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science
  • Drug Discovery

Fingerprint

Dive into the research topics of 'In vitro effects of ivermectin upon trichomonas vaginalis trophozoites'. Together they form a unique fingerprint.

Cite this